However, some CRGs with CNV loss, such as IDH2, MTHFD1L, and ABCE1, showed upregulated mRNA expression, while other CRGs with CNV gain, such as TPK1, showed downregulated mRNA expression between tumor and normal samples. This evidence concerns the gene IDH2 and neoplasm.